Peninsula & South Eastern Haematology and Oncology Group — Frankston, Victoria

Public research footprint of Peninsula & South Eastern Haematology and Oncology Group, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Solid Tumor · Malignant Pleural Mesothelioma (MPM) · Squamous Cell Carcinoma

Recently updated registry entries

NCT05267626 — Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in… (Recruiting)
NCT07255404 — A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well… (Recruiting)
NCT06712355 — Safety and Efficacy of BNT327, an Investigational Therapy in Combination With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Peninsula & South Eastern Haematology and Oncology Group?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.